Major Clinical Issues in Hypertrophic Cardiomyopathy

Citations

WEB OF SCIENCE

33
Citations

SCOPUS

35

초록

Hypertrophic cardiomyopathy (HCM) is one of the most common inheritable cardiomyopathies. Contemporary management strategies, including the advent of implantable cardioverter-defibrillators and effective anticoagulation, have substantially improved the clinical course of HCM patients; however, the disease burden of HCM is still high in Korea. Sudden cardiac death (SCD), atrial fibrillation and thromboembolic risk, dynamic left ventricular outflow tract (LVOT) obstruction, and heart failure (HF) progression remain important issues in HCM. SCD in HCM can be effectively prevented with implantable cardioverter-defibrillators. However, appropriate patient selection is important for primary prevention, and the 5-year SCD risk score and the presence of major SCD risk factors should be considered. Anticoagulation should be initiated in all HCM patients with atrial fibrillation regardless of the CHA2DS2-VASc score, and non-vitamin K antagonist oral anticoagulants are the first option. Symptomatic dynamic LVOT obstruction is first treated medically with negative inotropes, and if symptoms persist, septal reduction therapy is considered. The recently approved myosin inhibitor mavacamten is promising. HF in HCM is usually related to diastolic dysfunction, while about 5% of HCM patients show reduced left ventricular ejection fraction <50%, also referred to as "end-stage" HCM. Myocardial fibrosis plays an important role in the progression to advanced HF in patients with HCM. Patients who do not respond to guideline-directed medical therapy can be considered for heart transplantation. The development of imaging techniques, such as myocardial deformation on echocardiography and late gadolinium enhancement on cardiac magnetic resonance, can provide better risk evaluation and decision-making for management strategies in HCM.

키워드

Hypertrophic cardiomyopathy; Sudden cardiac death; Atrial fibrillation; Ventricular outflow obstruction; Heart failure; LATE GADOLINIUM ENHANCEMENT; VENTRICULAR INSERTION POINTS; CARDIAC MAGNETIC-RESONANCE; LEFT ATRIAL PRESSURE; HEART-FAILURE; SUDDEN-DEATH; EUROPEAN ASSOCIATION; AMERICAN-COLLEGE; PROGNOSTIC VALUE; EXPLORER-HCM
제목
Major Clinical Issues in Hypertrophic Cardiomyopathy
저자
Lee, Hyun-Jung; Kim, Jihoon; Chang, Sung-A; Kim, Yong-Jin; Kim, Hyung-Kwan; Lee, Sang Chol
DOI
10.4070/kcj.2022.0159
발행일
2022-08
유형
Review
저널명
Korean Circulation Journal
권
52
호
8
페이지
563 ~ 575